Evotec SE (EVO) EBIT (2009 - 2025)

Evotec SE (EVO) reported EBIT of $44000.8 for Q4 2025, up 635.29% on a YoY basis from $5984.1 in Q4 2024, and up 184.58% sequentially from -$52025.3 in Q3 2025.

Evotec SE (EVO) EBIT (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of EBIT data on file, last reported at $44000.8 in Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 635.29% year-over-year to $44000.8; the trailing twelve-month figure through Dec 2025 stood at -$31135.4 (up 35.85% YoY), and the FY2025 full-year result was -$86721.2, down 56850.47% from the prior year.
  • EBIT rose to $44000.8 in Q4 2025, from -$52025.3 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $71672.5 in Q1 2022 to a low of -$52025.3 in Q3 2025.
  • A 5-year average of $5966.3 and a median of $8162.6 in 2021 frame the typical range for EBIT.
  • Across the five-year window, EBIT plunged 882.27% in 2023 and jumped 635.29% in 2025, its largest moves.
  • Tracing EVO's EBIT over 5 years: stood at $29803.9 in 2021, then sank by 157.63% to -$17176.9 in 2022, then plunged by 125.25% to -$38690.8 in 2023, then jumped by 115.47% to $5984.1 in 2024, then jumped by 635.29% to $44000.8 in 2025.
  • Business Quant data shows EVO's EBIT at $44000.8 in Q4 2025, -$52025.3 in Q3 2025, and $5984.1 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 44,000.84
Sep 30, 2025 -52,025.29
Dec 31, 2024 5,984.13
Sep 30, 2024 -29,095.13
Dec 31, 2023 -38,690.80
Sep 30, 2023 13,266.65
Jun 30, 2023 -39,514.89
Dec 31, 2022 -17,176.88
Sep 30, 2022 13,640.94
Jun 30, 2022 -4,022.80
Mar 31, 2022 71,672.49
Dec 31, 2021 29,803.88
Sep 30, 2021 20,918.20
Jun 30, 2021 8,162.55
Mar 31, 2021 62,571.09
Dec 31, 2020 198,429.22
Sep 30, 2020 21,663.16
Dec 31, 2019 69.41 Mn
Sep 30, 2010 867.74
Jun 30, 2010 2,315.10